Emergent Biosolutions Company Profile (NYSE:EBS)

About Emergent Biosolutions

Emergent BioSolutions Inc. is a biopharmaceutical company that offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company develops, manufactures and delivers a portfolio of medical countermeasures primarily for government agencies in the areas of biological and chemical threats and emerging infectious diseases (EID). It also develops and commercializes therapeutics in areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Its two operating divisions include Biodefense and Biosciences. The Biodefense division is a pharmaceutical business focused on countermeasures that address public health threats, including chemical, biological, radiological, nuclear and explosives (CBRNE) threats, as well as EID. The Biosciences division is a pharmaceutical business focused on therapeutics in hematology/oncology with secondary on transplantation, infectious disease and autoimmunity.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: Biotechnology
Exchange: NYSE
Symbol: EBS
CUSIP: 29089Q10

Key Metrics:

Previous Close: $28.36
50 Day Moving Average: $27.61
200 Day Moving Average: $34.28
52-Week Range: $40,458,000.00 - $26.12
Trailing P/E Ratio: 20.29
Foreward P/E Ratio: 14.04
P/E Growth: 1.25
Market Cap: $1.15B
Outstanding Shares: 40,458,000
Beta: 1.24

Profitability:

Net Margins: 11.61%
Return on Equity: 11.93%
Return on Assets: 7.56%

Debt:

Debt-to-Equity Ratio: 0.37%
Current Ratio: 5.08%
Quick Ratio: 4.15%

Additional Links:

Companies Related to Emergent Biosolutions:

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)

Ratings Breakdown:	1 Hold Rating, 4 Buy Ratings
Consensus Rating:	Buy (Score: 2.80)
Consensus Price Target:	$39.00 (39.63% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)

Show:

Date	Firm	Action	Rating	Price Target
8/7/2016	Cowen and Company	Reiterated Rating	Hold	$33.00
8/5/2016	JPMorgan Chase & Co.	Lower Price Target	Overweight	$45.00 -> $36.00
6/28/2016	Singular Research	Lower Price Target	Buy	$44.00 -> $40.00
6/22/2016	Wells Fargo & Co.	Reiterated Rating	Buy
5/2/2016	Chardan Capital	Reiterated Rating	Buy
3/6/2015	Summer Street	Reiterated Rating	Buy	$35.00

(Data available from 9/26/2014 forward)

Earnings History for Emergent Biosolutions (NYSE:EBS)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/3/2016
8/4/2016	Q2	($0.17)	($0.18)	$111.20 million	$101.49 million	View	Listen
5/5/2016	Q1	($0.07)	$0.16	$101.83 million	$111.00 million	View	Listen
2/25/2016	Q4	$0.70	$0.78	$168.07 million	$168.10 million	View	Listen
11/5/2015	Q315	$0.55	$0.83	$151.42 million	$164.90 million	View	Listen
8/6/2015	Q215	$0.18	$0.36	$114.25 million	$126.10 million	View	Listen
5/7/2015	Q1	($0.45)	($0.50)	$62.70 million	$63.60 million	View	Listen
3/5/2015	Q115	$0.69	$0.75	$147.00 million	$148.00 million	View	Listen
11/6/2014	Q414	$0.52	$0.49	$126.90 million	$138.00 million	View	Listen
8/7/2014	Q214	$0.32	$0.25	$109.25 million	$110.30 million	View	Listen
5/8/2014	Q114	($0.14)	($0.55)	$57.30 million	$53.90 million	View	Listen
3/6/2014	Q413	$0.36	$0.42	$93.83 million	$94.10 million	View	Listen
11/7/2013	Q313	$0.21	$0.37	$79.13 million	$89.10 million	View	Listen
8/5/2013	Q2 2013	$0.21	$0.29	$75.73 million	$82.40 million	View	Listen
5/2/2013	Q1 2013	($0.14)	($0.22)	$46.17 million	$43.10 million	View	Listen
3/7/2013	Q4 2012	$0.44	$0.44	$95.09 million	$94.61 million	View	Listen
11/1/2012	Q312	$0.22	$0.18	$73.53 million	$66.60 million	View	N/A
8/2/2012		$0.21	$0.21			View	N/A
5/3/2012		($0.18)	($0.19)			View	N/A
3/8/2012		$0.72	$0.78			View	N/A
11/3/2011		($0.04)	$0.04			View	N/A
8/4/2011		$0.33	$0.40			View	N/A
5/5/2011		($0.52)	($0.64)			View	N/A
3/10/2011		$0.67	$0.76			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Emergent Biosolutions (NYSE:EBS)

Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $1.99 EPS

Dividend History for Emergent Biosolutions (NYSE:EBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Emergent Biosolutions (NYSE:EBS)

Insider Ownership Percentage: 17.20%
Institutional Ownership Percentage: 89.95%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/6/2016	George A Joulwan	Director	Sell	4,700	$44.12	$207,364.00
6/1/2016	Daniel Abdun-Nabi	CEO	Sell	8,699	$43.74	$380,494.26
5/27/2016	Fuad El-Hibri	Major Shareholder	Sell	9,835	$43.50	$427,822.50
5/26/2016	Fuad El-Hibri	Major Shareholder	Sell	39,759	$43.13	$1,714,805.67
5/25/2016	Fuad El-Hibri	Major Shareholder	Sell	85,000	$42.52	$3,614,200.00
5/25/2016	Zsolt Harsanyi	Director	Sell	27,867	$42.33	$1,179,610.11
5/24/2016	Fuad El-Hibri	Chairman	Sell	20,000	$42.26	$845,200.00
5/23/2016	Fuad El-Hibri	Chairman	Sell	45,000	$42.62	$1,917,900.00
5/20/2016	Daniel Abdun-Nabi	CEO	Sell	8,701	$42.00	$365,442.00
5/19/2016	Jerome M Hauer	Director	Sell	3,134	$41.22	$129,183.48
5/13/2016	Louis W Sullivan	Director	Sell	47,631	$39.21	$1,867,611.51
5/12/2016	Fuad El-Hibri	Major Shareholder	Sell	25,000	$38.71	$967,750.00
5/12/2016	Jerome M Hauer	Director	Sell	4,700	$38.50	$180,950.00
5/11/2016	Louis W Sullivan	Director	Sell	9,969	$39.25	$391,283.25
4/22/2016	Fuad El-Hibri	Major Shareholder	Sell	4,209	$40.50	$170,464.50
4/18/2016	Daniel Abdun-Nabi	CEO	Sell	8,702	$40.17	$349,559.34
4/18/2016	Fuad El-Hibri	Major Shareholder	Sell	20,791	$40.50	$842,035.50
4/6/2016	Fuad El-Hibri	Major Shareholder	Sell	50,000	$39.00	$1,950,000.00
4/6/2016	Robert Kramer	EVP	Sell	21,786	$38.90	$847,475.40
4/4/2016	Robert Kramer	EVP	Sell	21,788	$36.90	$803,977.20
4/1/2016	Robert Kramer	EVP	Sell	43,572	$35.56	$1,549,420.32
3/14/2016	Adam Havey	EVP	Sell	4,359	$33.96	$148,031.64
3/14/2016	Jerome M Hauer	Director	Sell	2,350	$33.88	$79,618.00
3/11/2016	Adam Havey	EVP	Sell	11,112	$33.84	$376,030.08
3/11/2016	Louis W Sullivan	Director	Sell	14,879	$34.03	$506,332.37
3/7/2016	Marvin L White	Director	Sell	33,134	$35.42	$1,173,606.28
1/4/2016	Sue Bailey	Director	Sell	11,520	$38.79	$446,860.80
12/30/2015	Ronald Richard	Director	Sell	21,600	$40.00	$864,000.00
12/24/2015	Daniel Abdun-Nabi	CEO	Sell	63,209	$39.06	$2,468,943.54
11/19/2015	Fuad El-Hibri	major shareholder	Sell	17,871	$37.50	$670,162.50
11/13/2015	Fuad El-Hibri	major shareholder	Sell	13,013	$36.50	$474,974.50
11/12/2015	Barry Labinger	EVP	Sell	36,126	$35.64	$1,287,530.64
11/9/2015	Fuad El-Hibri	major shareholder	Sell	13,225	$35.50	$469,487.50
11/6/2015	Fuad El-Hibri	major shareholder	Sell	13,450	$34.50	$464,025.00
11/3/2015	Fuad El-Hibri	major shareholder	Sell	13,689	$33.50	$458,581.50
9/11/2015	Sue Bailey	Director	Sell	6,080	$32.37	$196,809.60
8/13/2015	George A Joulwan	Director	Sell	7,200	$34.72	$249,984.00
7/20/2015	Fuad El-Hibri	Chairman	Sell	234	$34.50	$8,073.00
7/13/2015	Ronald Richard	Director	Sell	4,922	$34.00	$167,348.00
6/29/2015	Ronald Richard	Director	Sell	4,923	$32.76	$161,277.48
6/22/2015	Fuad El-Hibri	Major Shareholder	Sell	74,564	$32.60	$2,430,786.40
6/16/2015	Louis W Sullivan	Director	Sell	13,457	$31.33	$421,607.81
6/15/2015	Adam Havey	EVP	Sell	36,298	$31.55	$1,145,201.90
6/15/2015	Fuad El-Hibri	Major Shareholder	Sell	45,436	$32.18	$1,462,130.48
1/20/2015	Fuad El-Hibri	Major Shareholder	Sell	15,325	$27.67	$424,042.75
12/26/2014	Ronald Richard	Director	Sell	5,000	$28.00	$140,000.00
12/17/2014	Ronald Richard	Director	Sell	5,000	$27.00	$135,000.00
12/11/2014	Fuad El-Hibri	Major Shareholder	Sell	119,341	$26.00	$3,102,866.00
11/28/2014	Fuad El-Hibri	Major Shareholder	Sell	34,577	$25.00	$864,425.00
11/25/2014	Fuad El-Hibri	Major Shareholder	Sell	9,014	$25.00	$225,350.00
11/25/2014	Zsolt Harsanyi	Director	Sell	8,000	$24.82	$198,560.00
11/12/2014	Fuad El-Hibri	Major Shareholder	Sell	2,311	$25.00	$57,775.00
11/7/2014	Robert Kramer	CFO	Sell	2,625	$24.00	$63,000.00
4/16/2014	Robert Kramer	CFO	Sell	50,189	$24.34	$1,221,600.26
3/12/2014	Adam Havey	EVP	Sell	11,562	$27.50	$317,955.00
3/11/2014	Adam Havey	EVP	Sell	17,655	$26.96	$475,978.80

(Data available from 1/1/2013 forward)

Latest Headlines for Emergent Biosolutions (NYSE:EBS)

Date	Headline
	Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : September 26, 2016 (NYSE:EBS) www.capitalcube.com - September 26 at 9:28 AM
	2 Biotech Stocks News And Price Trends: Emergent BioSolutions, Inc. (NYSE:EBS), Achillion Pharmaceuticals, Inc ... - The Voice Registrar (NYSE:EBS) voiceregistrar.com - September 22 at 4:49 PM
	Investigation for Investors in Emergent Biosolutions Inc (NYSE:EBS) over Potential Wrongdoing by Certain Directors Announced (NYSE:EBS) www.4-traders.com - September 22 at 10:19 AM
	22.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS) www.publicnow.com - September 22 at 10:19 AM
	How Emergent BioSolutions, Inc. (NYSE:EBS) trades after earning ... - The Independent Republic (NYSE:EBS) theindependentrepublic.com - September 21 at 5:15 PM
	4700 Shares of Emergent Biosolutions Inc (EBS) Stock are sold by George A. Joulwan - DailyQuint (NYSE:EBS) dailyquint.com - September 21 at 9:02 AM
	21.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS) www.publicnow.com - September 21 at 9:02 AM
	8,699 Shares of Emergent Biosolutions Inc (EBS) Stock are sold by ... - DailyQuint (NYSE:EBS) dailyquint.com - September 19 at 3:37 PM
	2 Biotech Stocks News And Price Trends: CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), Emergent BioSolutions, Inc ... - The Voice Registrar (NYSE:EBS) voiceregistrar.com - September 19 at 3:37 PM
	19.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS) www.publicnow.com - September 19 at 9:24 AM
	EMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General & Kahn Swick & Foti, LLC Re... (NYSE:EBS) ih.advfn.com - September 17 at 9:28 AM
	EMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action ... (NYSE:EBS) www.businesswire.com - September 17 at 9:28 AM
	EMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Emergent BioSolutions, Inc. – EBS (NYSE:EBS) finance.yahoo.com - September 17 at 9:28 AM
	2-DAY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 17 at 9:28 AM
	UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 - EBS (NYSE:EBS) finance.yahoo.com - September 16 at 4:39 PM
	FINAL DEADLINE ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016 (NYSE:EBS) finance.yahoo.com - September 16 at 4:39 PM
	MONDAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 16 at 4:39 PM
	Analyst Projections and Growth Recap for Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS) www.kentuckypostnews.com - September 16 at 8:26 AM
	4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 15 at 5:04 PM
	Management Board Changes at Erste Group and Erste Bank (NYSE:EBS) www.publicnow.com - September 15 at 5:04 PM
	Short Information Review for: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS) www.kentuckypostnews.com - September 14 at 8:54 AM
	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action ... - GlobeNewswire (press release) (NYSE:EBS) globenewswire.com - September 14 at 8:54 AM
	GPM Reminds Investors of the September 19th Deadline in the Class Action Lawsuit Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 14 at 8:54 AM
	SEPTEMBER 19 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 14 at 8:54 AM
	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 – EBS (NYSE:EBS) finance.yahoo.com - September 14 at 8:54 AM
	6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 14 at 8:54 AM
	Stock Up Over the Past Five Trading Sessions: Emergent ... - Post News (NYSE:EBS) www.kentuckypostnews.com - September 13 at 9:36 AM
	Brower Piven Alerts Shareholders of September 19, 2016 Deadline in Class Action Lawsuit and Encourages Those With Losses in Excess of $100,000 From Investment in Emergent BioSolutions, Inc. to Contact the Firm - EBS (NYSE:EBS) finance.yahoo.com - September 13 at 9:36 AM
	7-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 13 at 9:36 AM
	Shares Lower Over the Past Quarter: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS) www.kentuckypostnews.com - September 11 at 9:15 AM
	INVESTOR ALERT Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE EBS) Investors of September 19 ... - EconoTimes (NYSE:EBS) www.econotimes.com - September 10 at 9:20 AM
	Which way Emergent BioSolutions, Inc. (NYSE:EBS) earnings may ... - The Voice Registrar (NYSE:EBS) voiceregistrar.com - September 10 at 9:20 AM
	INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS) www.businesswire.com - September 9 at 4:36 PM
	INVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors ... (NYSE:EBS) www.prnewswire.com - September 8 at 4:38 PM
	INVESTOR ALERT: Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE: EBS) Investors of September 19, 2016 Lead Plaintiff Deadline (NYSE:EBS) finance.yahoo.com - September 8 at 4:38 PM
	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016 (NYSE:EBS) finance.yahoo.com - September 8 at 4:38 PM
	DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 8 at 4:38 PM
	INVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 ... - PR Newswire (press release) (NYSE:EBS) www.prnewswire.com - September 7 at 4:53 PM
	INVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS (NYSE:EBS) finance.yahoo.com - September 7 at 4:53 PM
	Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation (NYSE:EBS) finance.yahoo.com - September 7 at 4:53 PM
	UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 7 at 4:53 PM
	Short Data Recap for: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS) www.kentuckypostnews.com - September 7 at 8:04 AM
	EBS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS) finance.yahoo.com - September 6 at 4:40 PM
	ETF’s with exposure to Emergent BioSolutions, Inc. : September 6, 2016 (NYSE:EBS) www.capitalcube.com - September 6 at 4:40 PM
	UPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS) finance.yahoo.com - September 6 at 4:40 PM
	News review of 2 biotech stocks: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Emergent BioSolutions, Inc. (NYSE ... - The Voice Registrar (NYSE:EBS) voiceregistrar.com - September 6 at 9:36 AM
	Medical Gases Market Size To Reach $15.1 Billion By 2024: Grand View Research, Inc. (NYSE:EBS) www.econotimes.com - September 5 at 4:26 PM
	Transdermal Drug Delivery System Market Worth $81.4 Billion By 2024: Grand View Research, Inc. (NYSE:EBS) www.econotimes.com - September 5 at 9:23 AM
	Stock Struggling for the Quarter: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS) www.kentuckypostnews.com - September 4 at 4:28 PM
	Rain Design unveils mStand series for Macbook, iPad and iPhone with Apple-matching colors at IFA Sep 2016 (NYSE:EBS) www.econotimes.com - September 4 at 9:13 AM